UnitedHealth Group Incorporated $UNH Shares Sold by BLI Banque de Luxembourg Investments

BLI Banque de Luxembourg Investments lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 24.1% in the fourth quarter, Holdings Channel.com reports. The firm owned 42,683 shares of the healthcare conglomerate’s stock after selling 13,537 shares during the quarter. BLI Banque de Luxembourg Investments’ holdings in UnitedHealth Group were worth $14,179,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently added to or reduced their stakes in UNH. Everett Harris & Co. CA increased its stake in shares of UnitedHealth Group by 17.5% during the 4th quarter. Everett Harris & Co. CA now owns 2,953 shares of the healthcare conglomerate’s stock worth $975,000 after purchasing an additional 440 shares in the last quarter. Fox Run Management L.L.C. purchased a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $1,148,000. TIAA Trust National Association increased its stake in shares of UnitedHealth Group by 0.3% during the 4th quarter. TIAA Trust National Association now owns 263,116 shares of the healthcare conglomerate’s stock worth $86,857,000 after purchasing an additional 872 shares in the last quarter. Cerity Partners LLC increased its stake in shares of UnitedHealth Group by 0.9% during the 4th quarter. Cerity Partners LLC now owns 266,341 shares of the healthcare conglomerate’s stock worth $87,922,000 after purchasing an additional 2,377 shares in the last quarter. Finally, West Family Investments Inc. grew its stake in UnitedHealth Group by 25.3% in the 4th quarter. West Family Investments Inc. now owns 4,547 shares of the healthcare conglomerate’s stock worth $1,501,000 after acquiring an additional 919 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $406.38 on Tuesday. The company’s fifty day moving average price is $350.90 and its two-hundred day moving average price is $324.27. The firm has a market capitalization of $369.05 billion, a P/E ratio of 30.69, a P/E/G ratio of 1.61 and a beta of 0.64. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $408.71. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.80 and a quick ratio of 0.80.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share for the quarter, topping the consensus estimate of $6.76 by $0.47. The company had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The company’s revenue was up 2.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 18.32 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 23rd. Stockholders of record on Monday, June 15th will be given a $2.32 dividend. This represents a $9.28 annualized dividend and a dividend yield of 2.3%. The ex-dividend date of this dividend is Monday, June 15th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s payout ratio is presently 66.77%.

Insider Buying and Selling at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 800 shares of the business’s stock in a transaction dated Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the sale, the chief executive officer owned 17,805 shares of the company’s stock, valued at $6,320,775. This represents a 4.30% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.28% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have commented on UNH. Truist Financial lifted their target price on shares of UnitedHealth Group from $395.00 to $440.00 and gave the stock a “buy” rating in a research note on Monday, June 1st. Royal Bank Of Canada lifted their target price on shares of UnitedHealth Group from $361.00 to $400.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 22nd. JPMorgan Chase & Co. lifted their target price on shares of UnitedHealth Group from $420.00 to $466.00 and gave the stock an “overweight” rating in a research note on Monday. Argus upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $400.00 price target on the stock in a report on Wednesday, April 22nd. Finally, Raymond James Financial upgraded shares of UnitedHealth Group from a “market perform” rating to an “outperform” rating and set a $330.00 price target on the stock in a report on Wednesday, April 1st. One investment analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $407.17.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.